Bacteriophages could help oncolytic viruses penetrate cold tumors
A 2026 review proposes that bacteriophage-derived delivery, barrier-breaching and immune-stimulation features could help oncolytic viruses penetrate cold tumors and stimulate ...
A 2026 review proposes that bacteriophage-derived delivery, barrier-breaching and immune-stimulation features could help oncolytic viruses penetrate cold tumors and stimulate ...
A new experimental study shows that a combination of vaccine-strain measles and mumps viruses synergistically kills HT-29 colorectal cancer cells ...
A new review in Molecular Biology Reports maps how interleukin-24, once known only as a melanoma differentiation gene, regulates hepatocellular ...
RNA sequencing reveals that persistent canine distemper virus infection reshapes immune, angiogenic, and metabolic gene expression in canine histiocytic sarcoma ...
A new review argues that patient-derived glioblastoma organoids could finally provide a realistic platform for testing immunotherapies, including oncolytic herpes ...
A meta-analysis of 38 clinical trials finds oncolytic herpes simplex virus therapy delivers modest anti-tumor activity across solid tumors, with ...
A new Perspective argues that next-generation oncolytic viruses act as antigen-agnostic in situ vaccines capable of priming de novo antitumor ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine